NOVYX · Research Peptide
Fragment 176-191 + Modified GRF (1-29) + Ipamorelin Multi-Peptide Research Blend (12 mg)
Tri-component architecture for advanced metabolic signaling research.
A premium NOVYX research blend combining Fragment 176-191, Modified GRF (1-29), and Ipamorelin in a single 12 mg lyophilized presentation. Designed for controlled laboratory studies exploring peptide signaling interactions and receptor pathway dynamics in metabolic research models. Produced under stringent research-grade standards for purity, consistency, and stability. For laboratory research use only. Not for human, therapeutic, or diagnostic use.
Pack: 12 mg research format
Technical profile
Product reference
fragment-176-191-mod-grf-ipamorelin-blend
Product group
Peptide
Category
Metabolic
Vial size
12 mg
Purity
0%
Form
Lyophilized Powder
Molecular weight
—
Molecular formula
—
Availability
In stock
Featured
Research presentation only. Product handling and laboratory use should follow the supplied technical documentation.
Yes
Published
Yes
Sequence
Component-specific research specification available on request
Specifications
Series
NŌVYX Blend Series
Presentation
5 mL × 1 research vial
Status
Research / professional use only
Storage
Store lyophilized vial at -20°C, protected from light and moisture. Keep sealed and avoid repeated freeze-thaw cycles. Following reconstitution, store at 2-8°C per laboratory protocols and minimize temperature fluctuations.
Handling
For research use only. Reconstitute under aseptic conditions using appropriate sterile diluent. Allow vial to equilibrate to room temperature before adding diluent, then swirl gently until fully dissolved. Do not shake vigorously. Use only by qualified research personnel.
